Effects of curcumin supplementation on insomnia and daytime sleepiness in young women with premenstrual syndrome and dysmenorrhea: A randomized clinical trial

Objective: Premenstrual syndrome and primary dysmenorrhea are common gynecological complaints that are associated with psychological disorders. There is increasing evidence for the neuroprotective properties of curcumin, a polyphenolic natural product. This study aimed to assess the effects of curcu...

Full description

Saved in:
Bibliographic Details
Main Authors: Saman Seyedabadi (Author), Zahra Sadat Hoseini (Author), Gordon A. Ferns (Author), Afsane Bahrami (Author)
Format: Book
Published: Mashhad University of Medical Sciences, 2023-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e29b46041ef24a7d9dd7d6d4425dabf2
042 |a dc 
100 1 0 |a Saman Seyedabadi  |e author 
700 1 0 |a Zahra Sadat Hoseini  |e author 
700 1 0 |a Gordon A. Ferns  |e author 
700 1 0 |a Afsane Bahrami  |e author 
245 0 0 |a Effects of curcumin supplementation on insomnia and daytime sleepiness in young women with premenstrual syndrome and dysmenorrhea: A randomized clinical trial 
260 |b Mashhad University of Medical Sciences,   |c 2023-11-01T00:00:00Z. 
500 |a 2228-7930 
500 |a 2228-7949 
500 |a 10.22038/ajp.2023.21916 
520 |a Objective: Premenstrual syndrome and primary dysmenorrhea are common gynecological complaints that are associated with psychological disorders. There is increasing evidence for the neuroprotective properties of curcumin, a polyphenolic natural product. This study aimed to assess the effects of curcumin on sleep complications in women with premenstrual syndrome and dysmenorrhea.Materials and Methods: This triple-masked, placebo-controlled clinical trial comprised 124 patients with both premenstrual syndrome and dysmenorrhea. Participants were randomly assigned to curcumin (n=57) or control (n=60) groups. Each participant received one capsule containing either 500 mg of curcumin plus piperine or placebo, daily, from 7 days before until 3 days after menstruation for three consecutive menstrual cycles. Insomnia and sleepiness were assessed using standard questionnaires.Results: Scores for insomnia and daytime sleepiness were directly correlated with the Premenstrual Syndrome Screening Tool (PSST) score (p<0.05), but not with the visual analogue scale (VAS) score at baseline (p>0.05). There was a non-significant reduction in insomnia and sleepiness scores in both curcumin and placebo groups after the study intervention. Whilst, improvement rate of insomnia status, daytime sleepiness severity, short sleep duration and difficult sleep initiation was not statistically significant between the curcumin and placebo groups.Conclusion: Curcumin does not significantly affect sleep disorders in young women with premenstrual syndrome and dysmenorrhea. 
546 |a EN 
690 |a insomnia 
690 |a menstruation 
690 |a sleepiness 
690 |a turmeric 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Avicenna Journal of Phytomedicine, Vol 13, Iss 6, Pp 585-596 (2023) 
787 0 |n https://ajp.mums.ac.ir/article_21916_7d7ddc60f7cf42e04733c9962234ce3c.pdf 
787 0 |n https://doaj.org/toc/2228-7930 
787 0 |n https://doaj.org/toc/2228-7949 
856 4 1 |u https://doaj.org/article/e29b46041ef24a7d9dd7d6d4425dabf2  |z Connect to this object online.